Eli Lilly and CoNYSE:LLY

Help
Symbol Lookup
    No Matches were found for
    Additional matches for ...
     
    Go
    OverviewChartsNewsFundamentalsEarningsReportsCalendarOptionsTechnical Insight

    Symbol Lookup

    Close

    Search Criteria

    Name or Symbol

    Security Type

    Fund Categories

    Market

    Expiration Filter

    Chain Type

    Submit
    Saturday May 18, 2013 3:51 PM ET. Data delayed 15 minutes.
    55.90
    -0.04 (-0.07%)
    Price HistoryRefresh
    Bid/Lots
    56.00/1
    Ask/Lots
    57.50/4
    Open/Prev Close
    55.97/55.94
    Day Range
    55.35-56.23
    52-Week Range
    39.93-58.41
    Vol/Avg Daily Vol
    3.8M/8.1M

    LLY Article

    Go

    May 15, 2013

    RPT-ANALYSIS-Amazon gets help to lure big business to the cloud
    6:59AM ET on Wednesday May 15, 2013 by Thomson Reuters
    Companies Mentioned: RAX, GOOG, HPQ, IBM, INFA, LLY, MSFT, NFLX, ORCL, PEGA, ADBE, AMZN, ATTU, BMC, CA, CTSH, VMW, EBAY

    (Repeats with no changes to text or headline)

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding ent...

    ANALYSIS-Amazon gets help to lure big business to the cloud
    12:00AM ET on Wednesday May 15, 2013 by Thomson Reuters
    Companies Mentioned: RAX, GOOG, HPQ, IBM, INFA, LLY, MSFT, NFLX, ORCL, PEGA, ADBE, AMZN, ATTU, BMC, CA, CTSH, VMW, EBAY

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding enterprise customers

    * Crucial as Amazon targets ...

    May 14, 2013

    Lilly Oncology to Release New Pipeline Data at ASCO 2013
    4:30PM ET on Tuesday May 14, 2013 by PR Newswire
    Companies Mentioned: LLY

    Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from May 31 - June 4, 20...

    Lilly Provides Update on CEO Dr. John Lechleiter
    9:00AM ET on Tuesday May 14, 2013 by PR Newswire
    Companies Mentioned: LLY

    Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, underwent scheduled surgery for a dilated aorta on Monday, May 13, 2013.

    Third Rock Ventures Expands and Strengthens Team
    8:00AM ET on Tuesday May 14, 2013 by Business Wire
    Companies Mentioned: LLY

    Third Rock Ventures, LLC, a venture capital firm focused on building healthcare companies, today announced that it has expanded and strengthened its team with several appointments and role changes. These additions al...

    May 13, 2013

    U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group
    6:05PM ET on Monday May 13, 2013 by Thomson Reuters
    Companies Mentioned: ESRX, PTX, HIW, HL, MGM, LIOX, LLY, LVS, NGPC, PCYC, PENN, GNRC, RIG, SQNM, DDD, TWGP, WTS, WYNN, APO, PFLT, RLJ, AB, AIG, CG, ACRE, ARO, LMCA, TWER, WCRX, AZO, BA, FWM, HASI, BYD, CDNS, CSC, DAR, DFT, DRQ, ENDP

    May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and...

    May 10, 2013

    REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
    11:49AM ET on Friday May 10, 2013 by Thomson Reuters
    Companies Mentioned: GILD, JNJ, LLY, MRK, PFE

    (Removes "XX" from headline)

    By Deena Beasley

    LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for t...

    UPDATE: Eli Lilly Shares Dip On Phase III Disappointment, Discontinues Product
    10:16AM ET on Friday May 10, 2013 by Midnight Trader
    Companies Mentioned: LLY
    10:16 AM EDT, 05/10/2013 (MidnightTrader) -- Shares in Eli Lilly (LLY) dipped 0.35% to $54.39 in morning trade after it announced disappointing Phase III clinical trial results from enzastaurin's PRELUDE study. The study explored the molecule as ...
    Eli Lilly Shares Dip On Phase III Disappointment, Discontinues Product
    8:08AM ET on Friday May 10, 2013 by Midnight Trader
    Companies Mentioned: LLY
    08:08 AM EDT, 05/10/2013 (MidnightTrader) -- Shares in Eli Lilly (LLY) took a hit in pre-market trade, falling over 1%, after it announced disappointing Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecul...
    Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
    8:00AM ET on Friday May 10, 2013 by PR Newswire
    Companies Mentioned: LLY

    Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL...

    ← Newer1234Older →

    K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

    GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

    3:51 PM May 18, 2013
    Copyright ©2013 TD Waterhouse Canada Inc. All rights reserved.
    Privacy Policy | Internet Security | Legal
    Quotes, News, and Fundamentals provided by
    View restrictions
    News provided by